Australian Senate committee decides against compensation for victims of infected blood

doi:10.1136/bmj.328.7455.1518-f

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Bob Burton

Canberra

An Australian Senate committee of inquiry into the infection of over 8000 people with hepatitis C from blood transfusions and blood products has proposed a fund to improve their access to healthcare services but ruled out a compensation scheme.

Canada and Ireland have instituted compensation schemes covering loss of income and medical costs and—along with Great Britain—the provision of lump sum payments. It was a model that the Senate committee baulked at.

Chairwoman of the committee, Senator Jan McLucas, said: “If we had gone down the route of a compensation tribunal, it is the view of the …